These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 31148905)

  • 1. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
    Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
    World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
    He Q; Ma L; Li Y; Li G
    BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
    Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study.
    Yu P; Du Y; Xu Z; Huang L; Cheng X
    World J Surg Oncol; 2019 Feb; 17(1):28. PubMed ID: 30728027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
    Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
    Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
    Wada T; Yoshikawa T; Sekine S; Kamiya A; Hayashi T; Otsuki S; Yamagata Y; Katai H
    Eur J Surg Oncol; 2022 Feb; 48(2):333-338. PubMed ID: 34284903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
    Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
    J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer: initial Egyptian experience at the National Cancer Institute.
    Abdelhamed MA; Abdellatif A; Touny A; Mahmoud AM; Ahmed IS; Maamoun S; Shalaby M
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):10. PubMed ID: 32372263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?
    Zhang J; Zou S; Luo R; Zhu Z; Wang Z; Xu H; Huang B
    Clin Transl Oncol; 2019 Dec; 21(12):1699-1706. PubMed ID: 30977046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Para-aortic lymph node dissection following neoadjuvant chemotherapy for type 4 or large type 3 gastric cancer with extensive lymph node metastasis.
    Wada T; Yoshikawa T; Honda S; Fujisaki Y; Uotani T; Kumamoto Y; Ogawa R; Nishino M; Sakon R; Ishizu K; Hayashi T; Yamagata Y; Seto Y
    World J Surg; 2024 Oct; 48(10):2487-2495. PubMed ID: 39267179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan.
    Lee JH; Paik YH; Lee JS; Song HJ; Ryu KW; Kim CG; Park SR; Kook MC; Kim YW; Bae JM
    Ann Surg Oncol; 2006 Sep; 13(9):1163-7. PubMed ID: 16952027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Dissection after Neoadjuvant Chemotherapy].
    Ogawa T; Choda Y; Ninomiya M; Nagai Y; Mimura N; Miyake S; Ishida M; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2205-2207. PubMed ID: 28133270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A good surgical field for para-aortic nodal dissection in gastric cancer by the Cattell-Braasch maneuver.
    Akita M; Maeda E; Ishida R; Morikawa T; Nishimura T; Abe K; Kozuki A; Tanaka T; Kaneda K
    Langenbecks Arch Surg; 2022 Nov; 407(7):3141-3146. PubMed ID: 35978050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors for Para-aortic Lymph Node Dissection After Neoadjuvant Chemotherapy for Gastric Cancer.
    Endo S; Ikenaga M; Yamada T; Tamura S; Sasaki YO
    Anticancer Res; 2020 Apr; 40(4):2351-2357. PubMed ID: 32234937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.